国家卫健委：我国跃居全球新药研发第二位

Core Insights - The press conference highlighted the achievements in health and wellness during the "14th Five-Year Plan" period, emphasizing the focus on high-quality completion of the plan [1] Group 1: New Drug Development - China's share of new drug research and development has surpassed 20% of the global total, positioning the country as the second-largest in new drug development worldwide [1] - Several domestic innovative drugs, including Sugliatin, Ensartinib, and Gomititin, have been approved and launched, filling gaps in their respective fields [1] - The domestically developed anti-tumor drug Zebutinib has received approval in multiple countries [1]